FDA Inspection 1122874 — Megafine Pharma (P) Limited
The FDA completed an inspection of Megafine Pharma (P) Limited on March 6, 2020 in Nashik. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- March 6, 2020
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Nashik (India)